Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
Could Training in Inhalation Technique During the Hospital Stay and Discharge Services From the Pharmacy Reduce the Rate of Readmissions for COPD Patients? - A Pilot Study
1 other identifier
interventional
40
1 country
1
Brief Summary
Inhalation drugs are essential in the treatment of COPD, in controlling symptoms and preventing exacerbations. The aim of this pilot study is to collect data necessary for the planning of future efficacy trials. We plan to assess the value of providing training in inhalation technique to hospitalized COPD patients. Data on rehospitalizations will be collected from the hospital's medical records and from the National Patient Registry . The inhalation technique of all recruited patients will de assessed at baseline. The patients will then be randomised 1:1 to the intervention or standard care group. The intervention consists of a drug counselling, focusing on inhalation technique. In addition patients in the intervention group will have their medicines personally delivered from the hospital pharmacy at discharge (discharge service). Patients will be asked to fill in questionnaires evaluating the inhalation training and the discharge service
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 26, 2018
CompletedFirst Submitted
Initial submission to the registry
September 28, 2018
CompletedFirst Posted
Study publicly available on registry
October 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2021
CompletedFebruary 25, 2021
March 1, 2020
2.1 years
September 28, 2018
February 23, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Time to first readmission
Time to readmission based on data from the national patient registry
One year after discharge of the last patient
Secondary Outcomes (2)
Improvement in patient reported symptom score (CAT-score) from baseline to 2 months after discharge
2 months after discharge
Proportion of patients readmitted 3 months after discharge
3 months
Study Arms (2)
Intervention
EXPERIMENTALPatients receive an inhalation technique education based on standardized procedure developed by The Norwegian Pharmacy Association. In addition they are offered a discharge service day before or the day of discharge; a second inhalation training and dispensing of their prescribed COPD- medicines.
Standard care
NO INTERVENTIONPatients receive standard care and follow up of their COPD-treatment
Interventions
Patient drug counselling one-to-one, focusing on inhalation drugs and technique
Eligibility Criteria
You may qualify if:
- Patients admitted to the pulmonary ward, the Medical Department, Oslo University Hospital, Oslo, Norway
You may not qualify if:
- Patients
- previously included to the study
- usually not administering their inhalation drugs themselves
- using nebulizer chamber with their drug
- who are contagious, thus restricting accessibility of personnel
- who are not able to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Collegelead
- Oslo University Hospitalcollaborator
- Hospital Pharmacy Enterprise, South Eastern Norwaycollaborator
Study Sites (1)
Oslo University Hospital
Oslo, N-0424, Norway
Related Publications (1)
Kebede AT, Trapnes E, Lea M, Abrahamsen B, Mathiesen L. Effect of pharmacist-led inhaler technique assessment service on readmissions in hospitalized COPD patients: a randomized, controlled pilot study. BMC Pulm Med. 2022 May 27;22(1):210. doi: 10.1186/s12890-022-02004-z.
PMID: 35624509DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liv Mathiesen, PhD
Oslo University Collage
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
September 28, 2018
First Posted
October 1, 2018
Study Start
September 26, 2018
Primary Completion
November 15, 2020
Study Completion
January 15, 2021
Last Updated
February 25, 2021
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share
Sharing of individual patient data is not allowed by the approving authority